All data are based on the daily closing price as of May 16, 2025
o
Olympus
7733.TSE
12.88 USD
-0.17
-1.30%
Overview
Last close
12.88 usd
Market cap
14.53B usd
52 week high
19.88 usd
52 week low
11.24 usd
Target price
17.63 usd
Valuation
P/E
18.2154
Forward P/E
19.1939
Price/Sales
2.1169
Price/Book Value
2.8085
Enterprise Value
14.32B usd
EV/Revenue
2.0911
EV/EBITDA
8.9752
Key financials
Revenue TTM
6.85B usd
Gross Profit TTM
4.69B usd
EBITDA TTM
1.58B usd
Earnings per Share
0.71 usd
Dividend
0.14 usd
Total assets
9.00B usd
Net debt
83.66M usd
About
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.